Zafgen, Inc.
Records under this name other than patents Zafgen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,260,419 | Polymorphic salt of a metap-2 inhibitor and methods of making and using same Lapsed on the fee record Ended Feb 16, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 16, 2024 | From the USPTO record |
| US 9,221,787 | Sulphonamine compounds and methods of making and using same Lapsed on the fee record Ended Dec 29, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 29, 2023 | From the USPTO record |
| US 9,187,494 | Aryl-substituted tricyclic sulfonamides as methionyl aminopeptidase 2 modulators Lapsed on the fee record Ended Nov 17, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 17, 2023 | From the USPTO record |
| US 9,173,865 | Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol Lapsed on the fee record Ended Nov 3, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 3, 2023 | From the USPTO record |
| US 10,406,134 | Methods of Treating an Overweight Subject Formerly held Lapsed on the fee record Ended Sep 10, 2023 · Medium confidence | Lapsed on the fee record | Ended Sep 10, 2023 | Medium confidence |
| US 9,067,905 | Sulphone compounds and methods of making and using same Lapsed on the fee record Ended Jun 30, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 30, 2023 | From the USPTO record |
| US 9,067,913 | Fumigillol type compounds and methods of making and using same Lapsed on the fee record Ended Jun 30, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 30, 2023 | From the USPTO record |
| US 10,259,796 | Oxaspiro[2.5]octane derivatives and analogs Lapsed on the fee record Ended Apr 16, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 16, 2023 | From the USPTO record |
| US 9,000,035 | Treatment of obesity using non-daily administration of 6-O-(4-dimethylaminoethoxy) cinnamoyl fumagillol Lapsed on the fee record Ended Apr 7, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 7, 2023 | From the USPTO record |
| US 10,231,946 | Methods of treating ischemic organ damage and other disorders Lapsed on the fee record Ended Mar 19, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 19, 2023 | From the USPTO record |